Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
1997-4-24
|
pubmed:abstractText |
We investigated the role of leukotrienes (LT) in hyperoxia-induced changes in lung parenchyma in neonatal rat pups. Rat pups were exposed to 21% O(2) (air) or >95% O(2) from days 4 to 14 after birth and were administered the 5-lipoxygenase (5-LO) inhibitor and LTD4 receptor antagonist Wy-50295, 5-LO-activating protein inhibitor MK-0591, or vehicle from days 3 to 14. All measurements were done on days 12-14. There was a significant (P < 0.05) increase in peptido-LT output from lung slices of animals exposed to O(2) compared with air-exposed animals. Both Wy-50295 and MK-0591 significantly lowered (P < 0.05) peptido-LT output in O(2)-exposed animals. The 6-ketoprostaglandin F(1alpha) output was increased similarly in both vehicle- and drug-treated O(2)-exposed animals. O(2) exposure also caused a significant increase in bronchoalveolar lavage fluid protein and extravascular lung water that could not be ameliorated by Wy-50295 or MK-0591. Hyperoxia-induced inhibition of alveolarization, indicated by a significantly (P < 0.05) lower parenchymal tissue density, specific internal surface area, and airspace perimeter-to-area ratio, and a significantly (P < 0.05) higher mean linear intercept and airspace unit volume than air-exposed animals, was prevented by both Wy-50295 and MK-0591. Although hyperoxia had no effect on septal thickness, Wy-50295 caused significant thickening in both air- and O(2)-exposed pups. Our studies provide evidence that hyperoxia-induced peptido-LT may mediate O(2)-induced inhibition of alveolarization and that this is not caused by an arachidonic acid shunt to cyclooxygenase.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonate 5-Lipoxygenase,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Leukotrienes,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/MK 0591,
http://linkedlifedata.com/resource/pubmed/chemical/Naphthaleneacetic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines,
http://linkedlifedata.com/resource/pubmed/chemical/S(alpha)-methyl-6-(2-quinolinylmetho...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
272
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
L433-41
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9124600-Acute Disease,
pubmed-meshheading:9124600-Animals,
pubmed-meshheading:9124600-Animals, Newborn,
pubmed-meshheading:9124600-Arachidonate 5-Lipoxygenase,
pubmed-meshheading:9124600-Body Weight,
pubmed-meshheading:9124600-Female,
pubmed-meshheading:9124600-Hyperoxia,
pubmed-meshheading:9124600-Indoles,
pubmed-meshheading:9124600-Leukotrienes,
pubmed-meshheading:9124600-Lipoxygenase Inhibitors,
pubmed-meshheading:9124600-Lung,
pubmed-meshheading:9124600-Lung Injury,
pubmed-meshheading:9124600-Male,
pubmed-meshheading:9124600-Naphthaleneacetic Acids,
pubmed-meshheading:9124600-Pulmonary Alveoli,
pubmed-meshheading:9124600-Quinolines,
pubmed-meshheading:9124600-Rats,
pubmed-meshheading:9124600-Rats, Sprague-Dawley,
pubmed-meshheading:9124600-Time Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
|
pubmed:affiliation |
Department of Pediatrics, The University of Alberta, Edmonton, Canada.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|